Danaher Corporation $DHR Shares Acquired by Ally Financial Inc.

Key Points

• Ally Financial Inc. increased its stake in Danaher Corporation by 66.7%, acquiring an additional 10,000 shares during the first quarter, bringing its total holdings to 25,000 shares valued at $5.1 million.
• Danaher Corporation reported $1.80 earnings per share in its latest quarterly earnings, surpassing analyst expectations of $1.64, with revenues reaching $5.94 billion.
• Analysts have upgraded Danaher’s stock, with a consensus rating of "Moderate Buy" and an average price target of $247.61, indicating positive sentiment among investment professionals.

Ally Financial Inc. increased its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 66.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,000 shares of the conglomerate's stock after purchasing an additional 10,000 shares during the period. Ally Financial Inc.'s holdings in Danaher were worth $5,125,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Heck Capital Advisors LLC purchased a new position in Danaher during the fourth quarter valued at $27,000. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the first quarter worth about $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on DHR shares. Barclays reissued an "overweight" rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Robert W. Baird increased their price objective on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research report on Friday, July 18th. UBS Group decreased their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft dropped their price target on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 11.10% of the stock is owned by company insiders.

Danaher Trading Up 0.2%

Shares of DHR traded up $0.42 during trading hours on Thursday, reaching $205.42. 2,519,753 shares of the company traded hands, compared to its average volume of 4,185,368. The stock's fifty day moving average price is $201.23 and its 200 day moving average price is $199.46. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $147.09 billion, a price-to-earnings ratio of 43.71, a PEG ratio of 2.88 and a beta of 0.73. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the company posted $1.72 EPS. Danaher's revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.